Page 525 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 32 Acquired Disorders of Red Cell, White Cell, and Platelet Production 444.e1

REFERENCES 23. Maekawa K, Shibata J, Nakagawa S, et al: Pure red cell aplasia associ-
ated with renal cell carcinoma]. Nippon Naika Gakkai Zasshi 78:1002,
1. Marmont A, Peschle C, Sanguineti M, et al: Pure red cell aplasia 1989.
(PRCA): Response of three patients of cyclophosphamide and/or 24. Iannucci A, Perini A, Pizzolo G: Acquired pure red cell aplasia associ-
antilymphocyte globulin (ALG) and demonstration of two types of ated with thyroid carcinoma: Case report. Acta Haematol 69:62,
serum IgG inhibitors to erythropoiesis. Blood 45:247, 1975. 1983.
2. Jepson JH, Lowenstein L: Inhibition of erythropoiesis by a factor 25. Kobayashi M, Nukui A, Morita T: Pure red cell aplasia in a prostate
present in the plasma of patients with erythroblastopenia. Blood 27:425, cancer patient treated with leuprolide acetate and chlormadinone
1966. acetate. Int J Urol 12:1010, 2005.
3. Field EO, Caughi MN, Blackett NM, et al: Marrow-suppressing factors 26. Gajwani B, Zinner EN: Pure red-cell aplasia. Associated with adeno-
in the blood in pure red-cell aplasia, thymoma and Hodgkin’s disease. carcinoma of stomach. N Y State J Med 76:2177, 1976.
Br J Haematol 15:101, 1968. 27. Young NS, Brown KE: Parvovirus B19. N Engl J Med 350:586, 2004.
4. Jepson JH, Vas M: Decreased in vivo and in vitro erythropoiesis induced 28. Eridani S, Whitehead S, Sawyer B, et al: Pure red cell aplasia and
by plasma of ten patients with thymoma, lymphosarcoma, or idiopathic thymoma: Demonstration of persisting inhibition of erythropoiesis
erythroblastopenia. Cancer Res 34:1325, 1974. after thymectomy and resolution after immune suppressive treatment.
5. al Mondhiry H, Zanjani ED, Spivack M, et al: Pure red cell aplasia Clin Lab Haematol 8:181, 1986.
and thymoma: Loss of serum inhibitor of erythropoiesis following 29. Stricker RB, Goldberg B: AIDS and pure red cell aplasia. Am J Hematol
thymectomy. Blood 38:576, 1971. 54:264, 1997.
6. Chikkappa G, Zarrabi MH, Tsan MF: Pure red-cell aplasia in patients 30. Sao H, Yoshikawa H, Akao Y, et al: An adult case of acute erythroblas-
with chronic lymphocytic leukemia. Medicine (Baltimore) 65:339, topenia. Rinsho Ketsueki 23:1453, 1982.
1986. 31. Chehal A, Sharara AI, Haidar HA, et al: Acute viral hepatitis A and
7. Mangan KF, Chikkappa G, Farley PC: T gamma (T gamma) cells parvovirus B19 infections complicated by pure red cell aplasia and
suppress growth of erythroid colony-forming units in vitro in the pure autoimmune hemolytic anemia. J Hepatol 37:163, 2002.
red cell aplasia of B-cell chronic lymphocytic leukemia. J Clin Invest 32. Tomida S, Matsuzaki Y, Nishi M, et al: Severe acute hepatitis A associ-
70:1148, 1982. ated with acute pure red cell aplasia. J Gastroenterol 31:612, 1996.
8. Hoffman R, Kopel S, Hsu SD, et al: T cell chronic lymphocytic 33. Simmons J, Stein L, Kaufman A: Pure red cell aplasia and hepatitis A.
leukemia: Presence in bone marrow and peripheral blood of cells that South Med J 86:1274, 1993.
suppress erythropoiesis in vitro. Blood 52:255, 1978. 34. al Awami Y, Sears DA, Carrum G, et al: Pure red cell aplasia associated
9. Lipton JM, Nadler LM, Canellos GP, et al: Evidence for genetic restric- with hepatitis C infection. Am J Med Sci 314:113, 1997.
tion in the suppression of erythropoiesis by a unique subset of T 35. Ramos-Casals M, Garcia-Carrasco M, Lopez-Medrano F, et al: Severe
lymphocytes in man. J Clin Invest 72:694, 1983. autoimmune cytopenias in treatment-naive hepatitis C virus infection:
10. Tefferi A, Windebank KP, Veeder MH, et al: Steroid-responsive pure clinical description of 35 cases. Medicine (Baltimore) 82:87, 2003.
red cell aplasia associated with natural killer cell lymphocytosis. Am J 36. Solano C, Gomez-Reino F, Fernandez-Ranada JM: Pure red cell aplasia
Hematol 31:211, 1989. in kala-azar. Acta Haematol 72:205, 1984.
11. Partanen S, Ruutu T, Vuopio P, et al: Acquired pure red-cell aplasia: 37. Cavalcant J, Shadduck RK, Winkelstein A, et al: Red-cell hypoplasia
A consequence of increased natural killer cell activity? Leuk Res 8:117, and increased bone marrow reticulin in systemic lupus erythematosus:
1984. Reversal with corticosteroid therapy. Am J Hematol 5:253, 1978.
12. Levitt LJ, Reyes GR, Moonka DK, et al: Human T cell leukemia virus- 38. Dessypris EN, Baer MR, Sergent JS, et al: Rheumatoid arthritis and
I-associated T-suppressor cell inhibition of erythropoiesis in a patient pure red cell aplasia. Ann Intern Med 100:202, 1984.
with pure red cell aplasia and chronic T gamma-lymphoproliferative 39. Giordano N, Senesi M, Battisti E, et al: Sjögren’s syndrome and pure
disease. J Clin Invest 81:538, 1988. red cell aplasia. Clin Exp Rheumatol 14:344, 1996.
13. Abkowitz JL, Kadin ME, Powell JS, et al: Pure red cell aplasia: lympho- 40. Ramakrishna R, Chaudhuri K, Sturgess A, et al: Haematological
cyte inhibition of erythropoiesis. Br J Haematol 63:59, 1986. manifestations of primary Sjögren’s syndrome: a clinicopathological
14. Hara T, Mizuno Y, Nagata M, et al: Human gamma delta T-cell study. Q J Med 83:547, 1992.
receptor-positive cell-mediated inhibition of erythropoiesis in vitro in 41. Julkunen H, Jantti J, Pettersson T: Pure red cell aplasia in mixed con-
a patient with type I autoimmune polyglandular syndrome and pure nective tissue disease. J Rheumatol 16:1385, 1989.
red blood cell aplasia. Blood 75:941, 1990. 42. Trinchet JC, Lacombe C, Islam S, et al: Association of autoimmune
15. Tanaka Y, Matsui K, Yamashita K, et al: T-gamma delta large granular chronic active hepatitis and acquired erythroblastopenia cured by
lymphocyte leukemia preceded by pure red cell aplasia and complicated cyclophosphamide]. Gastroenterol Clin Biol 10:841, 1986.
with hemophagocytic syndrome caused by Epstein-Barr virus infection. 43. Jacob A, Sandhu K, Nicholas J, et al: Antibody-mediated pure red
Intern Med 45:631, 2006. cell aplasia in a dialysis patient receiving darbepoetin alfa as the sole
16. Orchard J, Myint H, Hamblin TJ: A patient with myeloma who still erythropoietic agent. Nephrol Dial Transplant 21:2963, 2006.
has pure red cell aplasia despite the most intensive immune modulation. 44. Shinohara K: Pure red cell aplasia caused by antibody to erythropoietin
Leuk Res 21:353, 1997. successfully treated by cyclosporine administration. Am J Hematol
17. Singh VP, Khanna A, Rai M, et al: Non-Hodgkin’s lymphoma with 82:247, 2007.
pure red cell aplasia. J Assoc Physicians India 49:1123, 2001. 45. Bolan CD, Leitman SF, Griffith LM, et al: Delayed donor red cell
18. Suzuki A, Takahashi T, Taniguchi A, et al: Pure red cell aplasia associ- chimerism and pure red cell aplasia following major ABO-incompatible
ated with non-Hodgkin’s lymphoma and hemolytic anemia. Jpn J Clin nonmyeloablative hematopoietic stem cell transplantation. Blood
Oncol 21:384, 1991. 98:1687, 2001.
19. Grigg AP, O’Flaherty E: Cyclosporin A for the treatment of pure red 46. Lee JH, Lee KH, Kim S, et al: Anti-A isoagglutinin as a risk factor for
cell aplasia associated with myelodysplasia. Leuk Lymphoma 42:1339, the development of pure red cell aplasia after major ABO-incompatible
2001. allogeneic bone marrow transplantation. Bone Marrow Transplant
20. De Alarcon PA, Miller ML, Stuart MJ: Erythroid hypoplasia. An 25:179, 2000.
unusual presentation of childhood acute lymphocytic leukemia. Am J 47. Rabitsch W, Knobl P, Prinz E, et al: Prolonged red cell aplasia after
Dis Child 132:763, 1978. major ABO-incompatible allogeneic hematopoietic stem cell trans-
21. Imamura N, Kuramoto A, Morimoto T, et al: Pure red cell aplasia plantation: Removal of persisting isohemagglutinins with Ig-Therasorb
associated with acute lymphoblastic leukaemia of pre-T-cell origin. Med immunoadsorption. Bone Marrow Transplant 32:1015, 2003.
J Aust 144:724, 1986. 48. Maschan AA, Skorobogatova EV, Balashov DN, et al: Successful treat-
22. Sallan SE, Buchanan GR: Selective erythroid aplasia during therapy for ment of pure red cell aplasia with a single dose of rituximab in a child
acute lymphoblastic leukemia. Pediatrics 59:895, 1977. after major ABO incompatible peripheral blood allogeneic stem cell